Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Apr 21, 2011 (rev. 1)

Premium

Epigenomics this week announced the appointment of Noel Doheny as CEO of the company's US subsidiary in Seattle.

Doheny will report to Geert Nygaard, CEO of Epigenomics AG, and will start in his new position in early May.

Doheny most recently served as CEO of OpGen from 2008 to 2009. Prior to this, he held positions as senior vice president for the molecular diagnostics division of Affymetrix; vice president of pre-analytical solutions and a member of the executive committee at Qiagen; and president and CEO of BioStar (now ThermoBioStar).

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.